We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Ritter Pharmaceuticals Announces Positive Results from RP-G28 Phase 2 Study

News   Jan 06, 2012

 
Ritter Pharmaceuticals Announces Positive Results from RP-G28 Phase 2 Study
 
 
Advertisement
 

RELATED ARTICLES

Food Poisoning Bacteria Causes Autoimmunity and May Be Linked to Alzheimer’s and Parkinson’s

News

Scientists have demonstrated that a Salmonella biofilm protein can cause autoimmune responses and arthritis in animals and postulate a link with neurodegenerative disease onset.

READ MORE

New Cancer Vaccine Ready for Human Trials

News

A new cancer vaccine, comprised of human antibodies fused with tumor-specific protein, is ready to begin human testing.

READ MORE

Sunflowers, “Supergenes” and Evolution

News

Massive blocks of genes—inherited together ‘plug and play’ style—may play a larger role in evolutionary adaption than previously thought, according to new research.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Applied Sciences

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE